Inactive

This is a RFQ to support CDRH in advancing FDA’s efforts to work with manufacturers to develop radiation therapy devices that incorporate principles of safety by design. Please provide a quote based o... This is a RFQ to support CDRH in advancing FDA’s efforts to work with manufacturers to develop radiation therapy devices that incorporate principles of safety by design. Please provide a quote based on the attached Statement of Work. All questions shall be submitted to the following email address james.samuels@fda.hhs.gov . Quotes are due NLT, August 31 2021 @3pm Eastern Standard Time to the following email addresses james.samuels@fda.hhs.gov .